Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Tokushima
Clinical trial register · Japan

Clinical Trials in Tokushima, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Fukuoka 551 Nagoya 517 Sapporo 398 Tokyo 369 Osaka 348
Narrow the registerReset
Recruitment status
Phase
Site location
Fukuoka551 Nagoya517 Sapporo398 Tokyo369 Osaka348
All 926 locations
Target enrolment
to

Trials with a site in Tokushima

20 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Regeneron Pharmaceuticals
Phase 3
270
Nagoya, Okayama, Tokushima, Kofu, Matsumoto-shi
2026-05-21
Recruiting
Astellas Pharma Inc
Phase 1/2
84
Sendai, Bunkyo-ku, Toyama, Kyoto, Tokushima
2026-04-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
Minato, Fukuoka, Tokushima
2026-03-23
By invitation
BioMarin Pharmaceutical
Phase 3
140
Osaka, Tokushima, Tokyo, Tottori
2025-06-20
Recruiting
Takeda
Phase 3
59
Nagoya, Kumamoto, Sendai, Kashihara, Higashi-Matsuyama, Ōtsu, Tokushima, Bunkyo-ku
2025-05-06
Recruiting
GlaxoSmithKline
Phase 3
514
Aichi, Gunma, Hiroshima, Hokkaido, Tokushima, Tokyo, Yamanashi
2024-12-12
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals
Phase 1/2
54
Sapporo, Tokushima, Ōta-ku, Kyoto
2024-08-28
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Osaka, Tokushima, Tokyo, Tottori
2024-06-17
Recruiting
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
NCT06342414Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma, Primary Liver Cancer
City of Hope Medical Center
Observational
400
Fukuoka, Kumamoto, Sapporo, Tokushima
2024-03-15
Recruiting
Yonsei University
Phase 2
198
Kurume, Fukushima, Tsu, Sendai, Niigata, Hidaka, Tokushima, Tokyo
2024-01-22
Recruiting
BioMarin Pharmaceutical
Observational
400
Kumamoto, Suita, Yonago, Tokushima, Tokyo
2023-11-27
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Fukuoka, Ota-Shi, Kobe, Tsukuba, Kita-gun, Yokohama, Tokushima, Wakayama
2023-09-22
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Gunma, Hiroshima, Hokkaido, Kanagawa, Miyagi, Shizuoka, Tokushima, Tokyo
2023-09-13
Active, closed
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
NCT05778071Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Alexion Pharmaceuticals, Inc.
Phase 3
165
Chiba, Kanazawa, Osaka, Tokushima, Tottori
2023-06-07
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Kashiwa-shi, Sapporo, Suita-shi, Tokushima, Koto-ku, Osaka
2022-05-03
Recruiting
Ipsen
Phase 1/2
240
Fukuoka, Shizuoka, Tokushima, Tokyo
2021-04-29
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Matsuyama, Nagoya, Niigata, Okayama, Tokushima, Tokyo
2019-07-09
Active, closed
BioMarin Pharmaceutical
Phase 2
73
Osaka, Saitama, Tokushima
2019-06-12
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
387
Nagoya, Kashiwa-shi, Maebashi, Kasama-shi, Kyoto, Hidaka, Tokushima, Shibuya-ku
2019-01-23
Active, closed
BioMarin Pharmaceutical
Phase 3
119
Osaka, Saitama, Tokushima
2017-12-12
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/tokushima

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies with a site in Tokushima.

How many clinical trials are recruiting in Tokushima?

13 of the 20 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Tokushima), 20 studies
PhaseStudiesRecruitingShare
Phase 39445%
Phase 1/25425%
Phase 23215%
Observational2210%
Phase 2/3115%

Most active sponsors

Lead sponsors with the most studies (Tokushima)
Lead sponsorStudiesRecruiting
BioMarin Pharmaceutical51
Regeneron Pharmaceuticals33
GlaxoSmithKline22
Seagen, a wholly owned subsidiary of Pfizer21
Alexion Pharmaceuticals, Inc.10
Astellas Pharma Inc11
City of Hope Medical Center11
Dizal Pharmaceuticals10
Ipsen11
Merck Sharp & Dohme LLC11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.